A pregnant cardiac client may have two or three prenatal care appointments a week between 28 and 32 weeks' gestation because:
a. pregnancy-induced hypertension develops during that gestational time frame
b. placental insufficiency may develop and compromise the fetus
c. the normal increase in blood volume may result in congestive heart failure
d. weight gain begins to accelerate and may increase the heart's workload
C
When a pregnant client has heart disease, the normal physiologic increase in blood volume, cardiac output, and heart rate may cause congestive heart failure (CHF). Hypertension may cause cardiac insufficiency.
You might also like to view...
A severely depressed client shows vegetative signs of depression. Interventions to be implemented
include (more than one answer may be correct) A. monitoring food and fluid intake. B. offering laxatives as needed. C. providing a quiet sleep environment. D. doubling the daily caffeine intake. E. restricting intake of processed foods.
Which problem is a common side effect of most drugs used to treat Parkinson's disease?
a. Asthma b. Hypotension c. Constipation d. Weight gain
A nurse assessing a 6 year old with cardiomyopathy would anticipate which of the following signs in his assessment? Select all that apply
1. A murmur with a thrill 2. Fatigue when eating 3. Dysrhythmia after playing with toy cars 4. Sweating while sitting in bed watching cartoons 5. Dizziness when standing at the bedside
A patient is receiving a combination of cyclophosphamide, doxorubicin, and 5-fluorouracil for the treatment of breast cancer given every 4 weeks. The patient's tumor is responding well, but the patient is complaining of swelling of the ankles and shortness of breath. Congestive heart failure is confirmed by ultrasound. Considering the toxicity profiles, what change in therapy would you recommend in this setting?
A. Replace 5-fluorouracil with methotrexate B. Replace doxorubicin with mitoxantrone C. Replace cyclophosphamide with cisplatin D. Add leucovorin to the treatment regimen E. Discontinue cyclophosphamide